Literature DB >> 20736255

Who benefits from treating prehypertension?

Ray Moynihan1.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20736255     DOI： 10.1136/bmj.c4442

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Big pharma: a story of success in a market economy.

Authors:  Joao Calinas-Correia
Journal:  Med Health Care Philos       Date:  2013-05

2.  Presence of baseline prehypertension and risk of incident stroke: a meta-analysis.

Authors:  M Lee; J L Saver; B Chang; K-H Chang; Q Hao; B Ovbiagele
Journal:  Neurology       Date:  2011-09-28       Impact factor: 9.910

3.  On markets and morals--(re-)establishing independent decision making in healthcare: a reply to Joao Calinas-Correia.

Authors:  Stephan Sahm
Journal:  Med Health Care Philos       Date:  2013-05

4.  Medicalization of global health 3: the medicalization of the non-communicable diseases agenda.

Authors:  Jocalyn Clark
Journal:  Glob Health Action       Date:  2014-05-16       Impact factor: 2.640

5.  On social plasticity: the transformative power of pharmaceuticals on health, nature and identity.

Authors:  Johanne Collin
Journal:  Sociol Health Illn       Date:  2015-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.